newsfilter
← Latest News
GlobeNewswire·

Genocea to Present at the ESMO Virtual Congress and Two Investor Conferences in September

CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that...